US · UNH · MEDICAL - HEALTHCARE PLANS
UnitedHealth Group Incorporated (UNH) intrinsic value and stock valuation
$339.85as of 2026-11-21 · Mkt cap 374.84B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
UnitedHealth Group Incorporated DCF and intrinsic value
InvestorsCraft values UNH with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from UNH’s statements →
UnitedHealth Group Incorporated Graham Number
Graham Number: $182.52d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Merck & Co., Inc. (MRK) $133.72
- Novartis AG (NVS) $150.47
- AstraZeneca PLC (AZN) $174.35
- Thermo Fisher Scientific Inc. (TMO) $669.54
- Novo Nordisk A/S (NVO) $37.82
- Abbott Laboratories (ABT) $103.00
- CVS Health Corp. (CVS) $80.84
- Elevance Health Inc. (ELV) $394.48
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B | $324.2B | $287.6B |
| Operating income | $19B | $32.3B | $32.4B | $28.4B | $24B |
| Net income | $12.1B | $14.4B | $22.4B | $20.1B | $17.3B |
| EPSd | $13.2M | $15.5M | $23.9M | $21.2M | $18.1M |
| Operating cash flow | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B |
| Capital expenditure | -$-3.62B | -$-3.5B | -$-3.39B | -$-2.8B | -$-2.45B |
| Free cash flow | $16.1B | $20.7B | $25.7B | $23.4B | $19.9B |
| Total assets | $309.6B | $298.3B | $273.7B | $245.7B | $212.2B |
| Total debt | $78.4B | $76.9B | $67.4B | $57.6B | $46B |
| Net debt | $54B | $51.6B | $42B | $34.3B | $24.6B |
| Total equity | $101.7B | $102.6B | $98.9B | $86.3B | $76.5B |
| Cash and short-term investments | $28.1B | $29.1B | $29.6B | $27.9B | $23.9B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B | $324.2B | $287.6B |
| Cost of revenue | $364.7B | $310.9B | $280.7B | $244.5B | $217.9B |
| Gross profit | $82.9B | $89.4B | $91B | $79.6B | $69.7B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other expenses | $64B | $57.1B | $58.6B | $51.2B | $45.7B |
| Operating expenses | $64B | $57.1B | $58.6B | $51.2B | $45.7B |
| Cost and expenses | $428.6B | $368B | $339.3B | $295.7B | $263.6B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $4B | $3.91B | $3.25B | $2.09B | $1.66B |
| Depreciation and amortization | $4.36B | $4.1B | $3.97B | $3.4B | $3.1B |
| Ebitda | $23.1B | $28.1B | $36.3B | $31.8B | $27.1B |
| Operating income | $19B | $32.3B | $32.4B | $28.4B | $24B |
| Total other income/expenses, net | -$-4.27B | -$-12.22B | -$-3.25B | -$-2.09B | -$-1.66B |
| Income before tax | $14.7B | $20.1B | $29.1B | $26.3B | $22.3B |
| Income tax expense | $1.89B | $4.83B | $5.97B | $5.7B | $4.58B |
| Net income | $12.1B | $14.4B | $22.4B | $20.1B | $17.3B |
| Weighted average shares outstanding | $910M | $929M | $928M | $934M | $943M |
| Weighted average diluted shares outstanding | $910M | $929M | $938M | $950M | $956M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $28.1B | $29.1B | $29.6B | $27.9B | $23.9B |
| Net receivables | $52.7B | $48.5B | $39B | $30.5B | $28.1B |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $90.6B | $85.8B | $78.4B | $69.1B | $61.8B |
| Property, plant and equipment, net | $10.8B | $10.6B | $11.5B | $10.1B | $8.97B |
| Goodwill and intangible assets | $131B | $130B | $118.9B | $107.8B | $85.8B |
| Long-term investments | $54.3B | $52.4B | $47.6B | $43.7B | $43.1B |
| Total non-current assets | $219B | $212.5B | $195.3B | $176.6B | $150.4B |
| Total assets | $309.6B | $298.3B | $273.7B | $245.7B | $212.2B |
| Accounts payable | $77.4B | $68.6B | $32B | $56.8B | $49.1B |
| Short-term debt | $6.07B | $4.55B | $5.31B | $3.11B | $3.62B |
| Deferred revenue | $3.41B | $3.32B | $3.36B | $3.08B | $2.57B |
| Total current liabilities | $114.9B | $103.8B | $99.1B | $89.2B | $78.3B |
| Long-term debt | $72.3B | $72.4B | $62.1B | $54.5B | $42.4B |
| Deferred revenue, non-current | $0.00 | $0.00 | $3.36B | $0.00 | -$-3.27B |
| Total non-current liabilities | $93B | $91.9B | $80.4B | $70.1B | $57.4B |
| Capital lease obligations | $0.00 | $0.00 | $3.86B | $0.00 | $0.00 |
| Total liabilities | $207.9B | $195.7B | $174.8B | $159.4B | $135.7B |
| Common stock | $9M | $9M | $9M | $9M | $10M |
| Retained earnings | $95.6B | $96B | $95.8B | $86.2B | $77.1B |
| Accumulated other comprehensive income (loss) | -$-2.06B | -$-3.39B | -$-7.03B | -$-8.39B | -$-5.38B |
| Total equity | $101.7B | $102.6B | $98.9B | $86.3B | $76.5B |
| Total investments | $58B | $56.2B | $51.8B | $48.3B | $45.6B |
| Total debt | $78.4B | $76.9B | $67.4B | $57.6B | $46B |
| Net debt | $54B | $51.6B | $42B | $34.3B | $24.6B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $12.8B | $15.2B | $22.4B | $20.1B | $17.3B |
| Depreciation and amortization | $4.36B | $4.1B | $3.97B | $3.4B | $3.1B |
| Stock-based compensation | $971M | $1.02B | $1.06B | $925M | $800M |
| Change in working capital | $2.28B | -$-808M | $1.64B | $2.25B | $1.52B |
| Accounts receivable | $0.00 | -$-1.44B | -$-3.11B | -$-2.52B | -$-1B |
| Inventory | $0.00 | $0.00 | $1.04B | $0.00 | -$-1.03B |
| Accounts payable | $0.00 | $2.46B | $3.52B | $1.96B | $3.86B |
| Net cash provided by operating activities | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B |
| Investments in property, plant and equipment | -$-3.62B | -$-3.5B | -$-3.39B | -$-2.8B | -$-2.45B |
| Acquisitions, net | -$-4.51B | -$-13.41B | -$-10.14B | -$-21.46B | -$-4.82B |
| Net cash used for investing activities | -$-8.69B | -$-20.53B | -$-15.57B | -$-28.48B | -$-10.37B |
| Common stock issued | $0.00 | $1.85B | $1.35B | $1.25B | $1.36B |
| Common stock repurchased | -$-5.55B | -$-9B | -$-8B | -$-7B | -$-5B |
| Dividends paid | -$-7.92B | -$-7.53B | -$-6.76B | -$-5.99B | -$-5.28B |
| Net cash used for financing activities | -$-11.64B | -$-3.51B | -$-11.53B | $4.23B | -$-7.46B |
| Net change in cash | $2.81B | -$-115M | $2.06B | $1.99B | $4.45B |
| Cash at end of period | $28.1B | $25.3B | $25.4B | $23.4B | $21.4B |
| Operating cash flow | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B |
| Capital expenditure | -$-3.62B | -$-3.5B | -$-3.39B | -$-2.8B | -$-2.45B |
| Free cash flow | $16.1B | $20.7B | $25.7B | $23.4B | $19.9B |
Line items
Line items
Line items
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
- CEO
- Stephen J. Hemsley
- Employees
- 390K
- Beta
- 0.63
Included in
Explore
Frequently asked questions
What is the intrinsic value of UnitedHealth Group Incorporated (UNH)?
UnitedHealth Group Incorporated (UNH) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is UNH undervalued?
UNH trades at a price of $339.85 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.